Praxis Precision Medicines
Biotechnology
Praxis Precision Medicines is a clinical-stage, central nervous system (CNS) precision neuroscience biopharmaceutical company that translates insights from genetic epilepsies into therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. It is publicly traded on Nasdaq under ticker PRAX and is transitioning toward commercialization of its first therapies.
- Cerebrum™ small molecule platform (ulixacaltamide, vormatrigine, relutrigine, PRAX-020, PRAX-050)
- Solidus™ antisense oligonucleotide platform (elsunersen, PRAX-080, PRAX-090, PRAX-100)
Open roles at Praxis Precision Medicines
2 matching roles
Remote · Manager
Remote eligibility: United States
$147k to $167k USD
- Management Occupations
- CMC
Posted 2 months ago
Source: Greenhouse
Remote · Manager
Remote eligibility: United States
$115k to $140k USD
- Management Occupations
- CMC
Posted 3 weeks ago
Source: Greenhouse
Showing 2 of 2 roles